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Background: The activity of Bruton’s tyrosine kinase (Btk) is important for the
maturation of B cells. A variety of point mutations in this enzyme result in a
severe human immunodeficiency known as X-linked agammaglobulinemia
(XLA). Btk contains a pleckstrin-homology (PH) domain that specifically binds
phosphatidylinositol 3,4,5-trisphosphate and, hence, responds to signalling via
phosphatidylinositol 3-kinase. Point mutations in the PH domain might abolish
membrane binding, preventing signalling via Btk. 
Results: We have determined the crystal structures of the wild-type PH domain
and a gain-of-function mutant E41K in complex with D-myo-inositol 1,3,4,5-tetra-
kisphosphate (Ins (1,3,4,5)P4). The inositol Ins (1,3,4,5)P4 binds to a site that is
similar to the inositol 1,4,5-trisphosphate binding site in the PH domain of
phospholipase C-δ. A second Ins (1,3,4,5)P4 molecule is associated with the
domain of the E41K mutant, suggesting a mechanism for its constitutive
interaction with membrane. The affinities of Ins (1,3,4,5)P4 to the wild type
(Kd = 40 nM), and several XLA-causing mutants have been measured using
isothermal titration calorimetry. 
Conclusions: Our data provide an explanation for the specificity and high
affinity of the interaction with phosphatidylinositol 3,4,5-trisphosphate and lead
to a classification of the XLA mutations that reside in the Btk PH domain. Mis-
sense mutations that do not simply destabilize the PH fold either directly affect
the interaction with the phosphates of the lipid head group or change
electrostatic properties of the lipid-binding site. One point mutation (Q127H)
cannot be explained by these facts, suggesting that the PH domain of Btk
carries an additional function such as interaction with a Gα protein.
Introduction
Non-receptor tyrosine kinases are key regulators of the
growth and differentiation of hematopoietic cells [1,2].
Mutations in the gene coding for Bruton’s tyrosine
kinase (Btk) cause a severe hereditary immunodefi-
ciency characterized by a block in the differentiation of
pre-B-cells in bone marrow [3–5]. This results in defi-
ciency of B cells and immunoglobulins and subsequently
leads to susceptibility to infectious diseases in X-linked
agammaglobulinemia (XLA) patients [6]. A similar but
milder immunodeficiency, the X chromosome linked
immunodeficiency (xid), is caused by a mutation in the
murine Btk gene [7,8]. 
Btk is the prototype of the Tec family of tyrosine kinases
[9]. In common with the kinases of the Src family, the
Tec kinases contain Src-homology 3 and 2 domains (SH3
and SH2), and a catalytic SH1 domain. In addition, they
contain an N-terminal pleckstrin-homology (PH) domain
and a Tec-homology (TH) domain (Figure 1a), which
seem to substitute for the N-terminal myristoylation site
that is necessary for membrane targeting of Src. The TH
domain is composed of a Btk motif adjacent to the PH
domain and proline-rich region [10].
Tec kinases are involved in a variety of signalling path-
ways stimulated by activation of different hematopoietic
receptors. The Btk activation is specifically triggered by
a variety of extracellular stimuli, including cross-linking
of the B-cell antigen receptor and binding of interleukin
5 [11,12]. Upon receptor stimulation, Tec kinases are
recruited to the membrane where they are phosphorylated
on a tyrosine (Y551) by a Src kinase, and hence activated.
Activation is completed by autophosphorylation on Y223
[13,14]. The XLA mutations in Btk map to all five
domains of the kinase, suggesting that they all are neces-
sary for correct signalling [15]. Several mis-sense muta-
tions have been found to map to the PH domain and the
Btk motif. This is the only case in which mutations within
a PH domain are known to cause a disease. 
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A key regulator of the membrane recruitment of Btk is
phosphoinositide 3-kinase (PI3K, [16]). PI3K phosphory-
lates phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2)
in the 3 position, generating phosphatidylinositol 3,4,5-
trisphosphate (PtdIns(3,4,5)P3) [17]. The PH domain of Btk
specifically recognizes and interacts with the latter [18].
Recent data show that the SH2-containing tyrosine phos-
phatase SHIP, which hydrolyses PtdIns(3,4,5)P3 to phos-
phatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) [19,20],
downregulates Btk activity [21], probably by decreasing
its membrane-binding affinity. This underlines the impor-
tant role of the PH domain in the response of Btk to regu-
latory stimuli.
Activation of Btk promotes growth and differentiation of B
cells through a variety of downstream effectors that are not
yet fully characterized. Phospholipase Cγ2, which hydrolyzes
PtdIns(4,5)P2 to diacyl glycerol and inositol 1,4,5-trisphos-
phate (Ins(1,4,5)P3) [22], has been identified as a target of
Btk [23,24]. The latter compound increases the intracellular
calcium flux [25] by opening the Ins(1,4,5)P3 receptor-gated
calcium stores and, hence, generates a sustained stimulatory
signal for B-cell development. 
Lipid interactions of PH domains
PH domains have low sequence similarity, but they share
a common fold consisting of a seven-stranded antiparallel
β sheet and a C-terminal α helix packing against it [26–28].
The PH domain of Btk has a second short α helix inserted
between β strands 5 and 6 (Figure 1b). The Btk motif, a
26-residue loop that forms a binding site for a zinc ion, is
essential for the structural stability of this PH domain
[29]. Several PH domains have been shown to bind phos-
pholipid head groups. They are characterized by a strong
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(a) Domain structure of Btk. (b) A structure-based multiple sequence
alignment of PH domains. Structural alignment of PH domain from Btk,
PLC-δ [31] (PDB entry 1mai), β-spectrin [38] (1btn), dynamin [28]
(1dyn) and pleckstrin [27] (1pls). (The first ten NMR structures were
used for the superimposition). Sequence alignment includes the PH
domains of cytohesin (Genbank accession number HSU70728) and
GRP-1 (Genbank MMAF1871). The secondary structure of the Btk PH
domain is shown below the alignment (blue arrows for β sheets and
red cylinders for α helices). The residues that are in contact with
Ins(1,3,4,5)P4 are coloured blue (for contacts with the sidechain) or
green (for contact with the backbone atoms). The Ins(1,4,5)P3-binding
residues in PLC-δ and in β-spectrin are coloured yellow and orange,
respectively. Residues showing chemical shifts upon Ins(1,4,5)P4
interaction in dynamin and in pleckstrin are coloured pink. The residues
mutated in XLA or xid disease are indicated above the corresponding
position. The E41 residue is marked in brown. An asterisk indicates the
invariant tryptophan present in PH domains. The numbering refers to
the Btk PH-domain sequence.
electrostatic polarization [30], and the binding site for phos-
phatidylinositols is located at the positive pole [26,31]. PH
domains show preferences for the binding of different
phosphatidylinositols [18,32]; their binding affinities vary
from the millimolar range (e.g. binding of the dynamin
domain to PtdIns(4,5)P2) down to the submicromolar range
(as in the case of the Btk-domain binding to PtdIns(3,4,5)P3
[18,33,34]). With respect to ligand specificity, they can be
divided into different groups. Several domains are promis-
cuous and bind different inositol lipids. Some PH domains
are more specific, however. For instance, the phospholipase
Cδ (PLC-δ) domain is specific to PtdIns(4,5)P2, the domain
of AKT/PKB kinase binds to PtdIns(3,4)P2 [35,36], and the
Btk, GRP-1 and cytohesin domains prefer PtdIns(3,4,5)P3
over other ligands [18,37].
Soluble inositol phosphates bind to the same sites in
PH domains with a similar affinity to phosphatidylinosi-
tol lipids. The crystal structures of the PH domains of
PLC-δ and spectrin have been determined in complex
with Ins(1,4,5)P3 [28,38]. Although the domains share a
common fold, the ligand-binding sites involve different
loops in the two proteins. However, both sites are located
at the positively charged pole. The crystal structure of
the xid mutant R28C of the Btk PH domain has been
recently determined in our laboratory [29]. On the basis
of this structure and XLA-mutant data, the binding site
for D-myo-inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4)
was predicted to occupy a position similar to that in
PLC-δ. The Btk domain has been reported to bind to
PtdIns(3,4,5)P3 and Ins(1,3,4,5)P4 with a Kd of 800 nM and
40 nM, respectively [18,39].
The XLA-causing mutations have been divided into two
main groups [29]. In one group, the mutations appear to
affect the global stability of the PH domain and thus could
be called ‘structural mutations’. In the other group, the
PH domain is properly folded, and these mutations may
have a functional defect such as a decreased affinity for
PtdIns(3,4,5)P3; we call them ‘functional mutations’. In
contrast, the E41K mutant has been isolated in a random-
mutagenesis study as a gain-of-function mutation [40].
Btk carrying this mutation was found to be constitutively
active. This mutant can transform mouse NIH3t3 fibro-
blasts, and it shows enhanced tyrosine phosphorylation
and enrichment to membranes in comparison with the
wild-type protein [41]. This suggests that the mutated PH
domain binds to membrane-bound ligands with a higher
affinity than the wild type domain in vivo. 
Here, we explore the basis for the binding specificity of
Ins(1,3,4,5)P4 to the Btk PH domain. Furthermore, we
want to understand the effect of the functional XLA
mutations within the PH domain. We have determined
the crystal structures of the wild-type and E41K-mutant
domains in complex with Ins(1,3,4,5)P4 and also used
isothermal titration calorimetry (ITC) to measure the
affinity and stoichiometry of the Ins(1,3,4,5)P4 binding of
several XLA mutants. 
Results and discussion
Crystal structures
The wild-type and E41K-mutant proteins containing the
PH domain and the Btk motif and corresponding to
residues 1–170 of human Btk were expressed in Escher-
ichia coli and purified as described previously [29]. Crystals
could not be obtained without the ligand. In contrast,
tetragonal crystals (space group I4122) grew in hanging
drops after overnight incubation at room temperature
when the two proteins were mixed with Ins(1,3,4,5)P4 in a
1:4 molar ratio (see the Materials and methods section).
Data were collected at a synchrotron facility (ESRF,
Grenoble) where crystals diffracted up to 2.1 Å resolution
in the case of the mutant and to 2.4 Å in the case of the
wild type. The structures were determined by molecular
replacement using the PH domain structure of the R28C
mutant as a template (Table 1). 
The Ins(1,3,4,5)P4 ligand was unambiguously positioned
in both E41K and wild-type domains from the analysis of
their electron-density maps (Figure 2). Structures were
refined to final R factors of 0.214 and 0.234 for the mutant
and wild-type domains, respectively. Two molecules were
found in the asymmetric unit in each structure together
with 274 and 208 water molecules, respectively. 
As expected, the overall structures of the unligated
(R28C) domain and the wild-type and E41K domains in
complex with the ligand are almost identical (Figures 3a
and b). However, a striking difference is found in the posi-
tion of loop β1–β2. In the R28C structure, it leans on the
Btk motif, forming several polar and hydrophobic interac-
tions. Nevertheless, it could not be properly modeled in
the unligated domain because of partial disorder in the
electron-density map [29]. This loop is involved in binding
Ins(1,3,4,5)P4 in each complex, and residues 15–23 undergo
a conformational change with movements of Cα atoms
ranging from 1.8 Å at position Q15 to 11.0 Å for residue
T20. The ligand promotes the loop movement and sta-
bilizes its conformation, rendering its electron density
clearly visible. This structural rearrangement leads to the
loss of the polar contacts between the Q16 sidechain and
the mainchain and sidechain atoms of N149, and the
hydrophobic interaction between the aliphatic part of the
Q16 sidechain and aromatic W147. This loss of stabilizing
interactions in this region of the β1–β2 loop is compen-
sated by a number of new contacts with the ligand, as
described below. 
Ins(1,3,4,5)P4-binding site 
The amino acids involved in the interaction with
Ins(1,3,4,5)P4 are located in the β1–β2 and β3–β4 loops.
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The ligand interacts with the PH domain directly,
forming 18 hydrogen bonds, and indirectly via several
water molecules (Figure 3c). Key residues coordinating
the ligand are K12 and R28, which interact with the
3- and 4-phosphates, and the residues on the β1–β2 loop,
which are involved in the interaction with the 5-phos-
phate. K12 contacts both 3- and 4-phosphates with two
and one hydrogen bonds, respectively. Indirectly, K12 is
also in contact with the OH group in the 2 position of the
inositol ring via a water molecule. The sidechain of R28
contacts the 3-phosphate with two hydrogen bonds.
These interactions completely bury the 3- and 4-phos-
phates in a cavity formed by loops β1–β2 and β3–β4. In
addition, the 4-phosphate directly interacts with the side-
chain of Y39 and the backbone NH group of Q15, and,
via two water molecules, with the backbone carbonyl
group of K53 and the sidechain of K17. The 3-phosphate
contacts the sidechain of K53 of strand β4 via a water
molecule (Figure 3c).
Residues 16–18 in the β1–β2 loop contact and stabilize the
5-phosphate. The backbone NH groups of these residues
interact with this phosphate via several hydrogen bonds.
Apart from the sidechain of K18, which also contacts the
5-phosphate, the sidechains of these residues are exposed
to the solvent and point away from the binding site. The
5-phosphate also interacts with the sidechain of S21. The
1-phosphate, which forms the link to the rest of the phos-
pholipid structure in PtdIns(3,4,5)P3, points away from the
binding site and interacts with the sidechains of N24 and
K26, and with water molecules. These water molecules
bridge the 1- and 3-phosphates to the sidechains of K53
and K18. Finally, the OH group in the 6 position of the
inositol ring is within hydrogen-bonding distance of the
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Figure 2
The Fo–Fc electron-density map of Ins(1,3,4,5)P4 bound to the PH
domain of the E41K mutant (chain A), contoured at 3σ. A similar
density is found for the ligand bound to the wild-type domain in the
corresponding position.
Table 1
Data collection and refinement statistics.
Wild type E41K
Resolution (Å) 35.0–2.4 35.0–2.1
Wavelength (Å) 0.947 0.947
Completeness*(%) 96.5(97.6) 99.4(99.5)
Rmerge*† 0.044(0.346) 0.037(0.322)
Number of unique reflections 25487 39294
Refinement statistics (TNT)
Resolution (Å) 2.4 2.1
R factor‡ 0.234 0.214
R free 0.351 0.296
Number of protein atoms (molecule A/molecule B) 1362/1348 1376/1338
Number of water molecules/zinc ions 208/2 274/2
Number of ligand molecules 2 4
Mean B of protein atoms (Å2; molecule A/molecule B) 55.3/62.5 34.1/44/9
Mean B of solvent atoms/zinc ions (Å2) 70.4/65.2 50.9/42.8
Mean B of ligand atoms (Å2; molecule A/molecule B) 44.62/54.34 28.16/34.11
55.4/55.6
Geometrical statistics
Rmsd from ideal bond length§ (Å) 0.022 0.020
Rmsd from ideal bond angles§ (°) 2.87 2.10
*Values in parentheses are for the highest shell. †Rmerge= Σ|Ii–<I>|/ΣIi, where Ii is the intensity of an individual reflection and <I> is the mean
intensity of that reflection. ‡R factor = Σ|Fo–Fc| / ΣFo. §Rmsd is root mean square deviation.
sidechain of S21, and the OH group in the 2 position is
hydrogen-bonded to the sidechain of N24, and the inositol
ring interacts via hydrophobic contacts with the sidechain
of S14 (Figure 3c).
Three elements, the sidechains of K12 and R28 on one
side, and the backbone NH group on the β1–β2 loop on the
other side, already provide a sufficiently high number of
contacts for positioning the 3-, 4- and 5-phosphates in a
stable interaction, which accounts for the high affinity and
specificity of the Btk PH domain for Ins(1,3,4,5)P4 over
Ins(1,4,5)P3. In competition experiments in vitro, the Kd for
the binding of the Btk domain to Ins(1,3,4,5)P4 has been
calculated to be 15 nM, whereas the Kds for Ins(1,4,5)P3 and
inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) have been esti-
mated to be in the micromolar range (54 and 11 µM, respec-
tively [42]). The crystal structure indicates that the absence
of a third phosphate group would deprive this interaction
of a significant number of hydrogen bonds; this would
explain the dramatic decrease in the affinity. The structure
also indicates that a phosphate in the 2 position would
sterically interfere with binding, whereas a 6-phosphate
could be accommodated. The binding experiments are con-
sistent with this, indicating that the Kd for the D-myo-inosi-
tol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) complex is
approximately 90 nM [42].
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Figure 3
(a) Comparison between the unligated Btk
PH-domain (R28C) structure, in orange, and
the wild-type domain bound to Ins(1,3,4,5)P4
in blue. The two structures were
superimposed by the program ALIGN [67].
Ins(1,3,4,5)P4 is in cyan and the bound zinc
ions in the Btk motif are in green. (b) The
E41K PH domain in complex with two
molecules of Ins(1,3,4,5)P4. The second
Ins(1,3,4,5)P4 molecule (pink) is bound
adjacent to the E41K mutation. Ins(1,3,4,5)P4
is in cyan and the zinc ion is in green. The
figure was prepared with the program SETOR
[68]. (c) Plot of the interactions between the
PH domain and Ins(1,3,4,5)P4 drawn with the
program LIGPLOT [69]. The E41K (chain A)
was chosen for the calculation because of its
higher resolution, but similar interactions are
seen in the wild-type domain. Only distances
below 3.5 Å are indicated (the distances will
be available at http://www.embl-heidelberg.de/
ExternalInfo/Saraste/projects.html).
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Comparison with inositol phosphate binding sites in other
PH domains
Seven different PH-domain structures have been deter-
mined by X-ray crystallography and/or nuclear magnetic
resonance (NMR) spectroscopy [26–29,31,38,43–46], but
only two have been solved in complex with an inositol-
phosphate ligand. The latter are the PLC-δ PH domain
[31], which binds Ins(1,4,5)P3 with a Kd of 210 nM, and
the β-spectrin PH domain [38], which binds the same
ligand with a much weaker affinity (Kd=40 µM). Ins(1,4,5)P3
binds to these two domains in distinct sites, which consist
of the β1–β2 and β1–β2 loops in the case of the β-spectrin
domain, and β1–β2 and β3/β4 loops in the case of the
PLC-δ domain.
As expected [29], the binding site in the Btk domain
has the same location as in the PLC-δ domain, namely
between the β1–β2 and β3–β4 loops. Furthermore, the
sidechains of K12 and R28 in the Btk domain superimpose
with K30 and R40 of the PLC-δ domains, which contact
the 4- and 5-phosphates of Ins(1,4,5)P3 in the latter [31]
(Figure 4). These two residues are also conserved in
GRP-1 and cytohesin PH domains (Figure 1b), which,
similar to the Btk domain, bind with a higher specificity to
PtdIns(3,4,5)P3 than to PtdIns(4,5)P2 [37].
Interestingly, the inositol ring in the PLC-δ complex is in a
position that is symmetrical to the one adopted in the Btk
complex (Figure 4). The Ins(1,3,4,5)P4 ligand of the latter
is rotated by 180° around the axis defined by the line con-
necting the 1- and 4-phosphates in comparison with the
Ins(1,4,5)P3 bound to the PLC-δ PH domain. Hence, the
3-phosphate in the Btk complex superimposes with the
5-phosphate of the PLC-δ complex, and together with
4-phosphate, is buried inside the interior of the binding
pocket. The crystal structure indicates that the phosphate
that chiefly accounts for the higher affinity of the Btk
complex with respect to the PLC-δ one is not the 3-phos-
phate but rather the 5-phosphate, which makes a number of
contacts with the backbone of the β1–β2 loop. This loop is
six residues shorter in the PLC-δ domain (Figure 1b) and
provides less stabilizing contacts to the Ins(1,4,5)P3 ligand,
leaving the 2 and 3 positions of the inositol ring solvent-
exposed. In the PLC-δ PH domain, the inositol ring
makes a hydrophobic contact with the sidechain of W36.
The sidechain of N24 in the Btk domain, which aligns with
W36 (Figure 1b), contacts the ligand with hydrogen bonds.
A hydrophobic contact with the inositol ring is made by the
sidechain of S14 in the Btk complex (Figure 3c).
The sidechains of K17, K18 and K19 in the loop β1–β2
are solvent-exposed and do not take part in the binding.
Positive residues are also found in the corresponding
sequences of GRP-1 and cytohesin PH domains (Figure 1b).
This suggests an important role for these residues in
building a positively charged array necessary for the correct
orientation and anchoring of the PH domain on negatively
charged membranes. 
The E41K mutant 
The Ins(1,3,4,5)P4-binding site in the E41K and wild-
type complexes is identical (Figure 3). The mutated residue
is located in the strand β3. This mutation, which replaces
a negative charge with a positive one, is responsible for
the constitutive membrane association and activation of
Btk [40], suggesting that the K41 residue would provide
more contacts with the bound Ins(1,3,4,5)P4 [29]. However,
the sidechain of K41 points away from the domain core
and is not in contact with the bound ligand (Figure 3b).
Comparison between the electron-density maps of the
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Figure 4
Comparison between the inositol phoshate
binding sites in the (a) Btk PH domain and 
(b) in the PLC-δ PH domain [31]. Only the
residues that are most important for the
interaction are indicated and coloured red and
orange. K12 and R28 in Btk superimpose
with K30 and R40 in PLC-δ. The
Ins(1,3,4,5)P4 in Btk and the Ins(1,4,5)P3 in
PLC-δ are in cyan.
mutant and wild-type PH domains revealed that a second
Ins(1,3,4,5)P4 molecule is bound to K41. The second
Ins(1,3,4,5)P4 is located on the crystallographic twofold
axis and is sandwiched between two symmetry-related
PH molecules that face each other in the crystal packing
(see the Materials and methods section). Unlike the other
ligand, it is not accommodated in a pocket, but it is in a
more exposed position and only makes contacts with the
sidechains of K26, K41 and K53. Its electron-density map
is more disordered in comparison with the map of the first
Ins(1,3,4,5)P4 in the pocket.
Comparison between the electrostatic potential of the
wild-type and the E41K mutant (Figure 5) reveals that
this mutation enlarges the positively charged surface in a
region located above β strands 3 and 4, where the second
Ins(1,3,4,5)P4 binds in the crystal. It is likely that other neg-
atively charged inositol phosphates, such as Ins(1,4,5)P3,
could be accommodated in this position to neutralize the
positive charge of K41. Therefore, this second interaction
may lack proper specificity and can be explained by the
increase in the local electrostatic potential.
Analysis of XLA mutations
The XLA mutations, which map to the PH domain and the
Btk motif [15] are shown in Figure 6. Structural mutations
occur in positions that are considered crucial for the folding
and stability of the domain. We have previously classified
mutations L11P, F25S, T33P, V64F, V113D and C155G/R
in this category [29]. During the course of this study, new
XLA mutations K19E, Y40C, I61N, S115F, T117P, Q127H
and C154S in the PH domain and Btk motif have been
added to the Btkbase (Figure 6). Y40 and I61 are in the
hydrophobic core of the PH domain. Their substitution
with cysteine and asparagine, respectively, would result in
structural instability. T117P and C154S can also be classi-
fied as structural mutations. T117 is found at the beginning
of the C-terminal α-helix. A proline in this position would
disrupt the structure of this α helix, which packs against the
β sheet and stabilizes the global fold. We have expressed
the T117P mutant and found that the protein is not soluble.
C154 coordinates the zinc ion, which is crucial for the
conformation of the loop corresponding to the Btk motif
[29]. Mutations in this position would unfold the Btk motif,
destabilizing the PH domain as well.
The rest of the mutations are predicted to impair the func-
tional properties of the PH domain without affecting the
core structure (Figure 6). Among these, the three mutations
of R28 are likely to perturb the interaction with inositol
phosphates. This residue is in contact with the 3-phosphate
of Ins(1,3,4,5)P4. All three mutations (R28C, R28H and
R28P) would remove the positive charge and would not
provide sidechains suitable for binding to the 3-phosphate.
Accordingly, the R28C and R28H mutants have been found
to bind to Ins(1,3,4,5)P4 with greatly reduced affinity [39].
The K12 sidechain lies in the middle of the binding pocket
contacting the 3- and 4-phosphates. The longer sidechains
of the K12R and S14F mutants would clash against the
ligand and sterically hinder its binding.
Interestingly, K19E and Q127H could both be functional
mutations (Figure 6). Each protein can be expressed in a
soluble form in E. coli. However, each residue is exposed
to the solvent and neither one is in contact with the
Ins(1,3,4,5)P4 molecule. K19 is located in the β1–β2 loop
but its sidechain points away from the bound ligand. Its
position mirrors the position of the lysine in the E41K
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Figure 5
The polarized electrostatic potential
contoured at +0.6 kT (solid blue and net
yellow) and –0.6 kT (orange). In (a), the
backbone of the domain with the E41K
mutation and the two ligands are shown (the
second Ins(1,3,4,5)P4 molecule is coloured
purple). In (b), the positive electrostatic
potential of the wild-type domain (solid blue)
and the E41K PH domain (net yellow), both
calculated without ligand, are superimposed.
The arrow indicates the position of the E41K
mutation. The figure was prepared with the
program INSIGHT II [70].
mutant, which is located on the opposite side of the
binding site in the β3–β4 loop (Figure 6). The E41K
mutation increases positive electrostatic potential at this
end of the domain, whereas the K19E mutation has an
opposite effect and consequently may decrease the affin-
ity for the negatively charged membrane surface.
We cannot explain the effect of Q127H substitution in
terms of perturbation of inositol-phosphate binding or the
electrostatic polarization. This residue is in the C-termi-
nal α helix, which is located on the opposite side of the
Ins(1,3,4,5)P4-binding pocket, and its sidechain is
solvent-exposed (Figure 6). It is tempting to think that
this XLA-causing mutation reflects a functional property
of the PH domain that is not related to phospholipid
binding. It has been proposed that some PH domains
bind to the Gβγ-subunit complex of heterotrimeric G pro-
teins [47]. Experimental data indicate that the Btk PH
domain may also bind to the Gβγ complex in a manner
similar to that of the PH domain of β-adrenergic receptor
kinase [48]. In addition, it has been reported that the Gα
subunit can stimulate Btk activity [49]. The residues
involved in binding to Gα12 have been mapped to the C
terminus of the PH domain and to the Btk motif [50].
The Q127 residue is located in this area, and the Q127H
mutation could abolish such an interaction.
Binding affinities 
We have expressed and purified several PH-domain
mutants to study their binding affinities to Ins(1,3,4,5)P4
by ITC [51]. According to the structural analysis, the loss-
of-function mutations K19E and Q127H, and the gain-of-
function mutation E41K should not alter binding affinity
to Ins(1,3,4,5)P4. The experimental data (Table 2 and
Figure 7) show that the wild type, Q127, K19E and E41K
bind to Ins(1,3,4,5)P4 with a similar affinity. 
The three mutants have an affinity in the range of
80–90 nM, which is only twofold lower than the affinity of
the wild-type domain (40 nM, Table 2). Conversely, the
binding isotherms of the functional mutants K12R and
R28C, which are predicted to affect the ligand binding,
were similar to the heat of dilution, indicating that no
detectable interaction takes place.
Under the conditions employed for the binding experi-
ments, the interaction between the Btk PH domain and
Ins(1,3,4,5)P4 is entropically driven, as it has a favorable
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Figure 7
A typical isothermal titration for the interaction of Ins(1,3,4,5)P4 with
Btk mutant Q127H. The points correspond to the enthalpy per molar
ratio (Ins(1,3,4,5)P4/protein), and the data have been fitted with a
nonlinear least-squares algorithm, giving KB = 1.26 × 107 M–1,
∆H = + 6.8 Kcal mol–1, and stoichiometry = 1.01 (Table 2).
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The point mutations causing the XLA or xid phenotype are shown.
The residues that are in contact with Ins(1,3,4,5)P4 and classified as
functional mutations are coloured red. Those residues that are not in
contact with Ins(1,3,4,5)P4, but are still classified as functional
mutations, are coloured yellow. Structural mutations are coloured
green. The E41K mutation is coloured orange. For a list of the
current XLA mutations [71] affecting the PH domain and Btk motif
see http://www.uta.fi/imt/bioinfo/BTKbase/. The two functional
mutations that are not in contact with the Ins(1,3,4,5)P4 ligand are
shown in bold. Folding mutants are L11P, F25S, T33P, Y40C/N,
I61N, V64F, V113D, S115F, T117P, C154S and C155G/R.
Functional mutants are: K12R, S14F, K19E, R28H, R28P, R28C
(xid) and Q127H.
entropic and a very small enthalpic contribution to the free
energy (Table 2). The entropic effect is likely to be attrib-
uted to the release of water molecules from the binding site
upon ligand interaction. The calculated stoichiometry of
the binding of the wild-type domain and the K19R, E41K
and Q127 mutants is equal to 1. This indicates that the
binding affinity of the second Ins(1,3,4,5)P4 that is present
in the crystal structure of the E41K mutant is too low to be
detected in solution, and it further supports the unspecific
character of the interaction with the second ligand.
Classification of the XLA mutants
Our data suggest that four kinds of mutants can been
identified. Structural mutations perturb the stability of the
PH-domain core or abolish binding of zinc to the adjacent
Btk motif. The bulk of the functional mutations weaken
binding of the PtdIns(3,4,5)P3 head group in a specific
binding site. The K19E mutation has an effect on the
electrostatic potential in the region surrounding the phos-
phatidylinositol-binding site. The reversal of an electric
charge in this region (E41K) can cause a gain of function.
Finally, none of the explanations above fits to the Q127H
mutation, which is predicted to perturb a different func-
tion such as the interaction with Gα12.
Dimerization of the PH domain and interaction with
membrane
Phosphatidylinositols phosphorylated in the 3 position,
such as PtdIns(3,4)P2 and PtdIns(3,4,5)P3, are not normally
present in the membranes of quiescent cells but they are
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Table 2
Titration calorimetry of the Ins(1,3,4,5)P4 binding to the Btk PH domains.
PH domain Stoichiometry KB KD ∆G° ∆H T∆S°
n (107 M–1) nM kcal/mol kcal/mol kcal/mol
wild type 1.0 ± 0.4 2.49 ± 0.63 40 –9.80 +6.7 ± 0.1 +16.5
E41K 1.0 ± 0.4 1.14 ± 0.37 87 –9.33 +6.4 ± 0.1 +15.7
K19E 1.0 ± 0.4 1.09 ± 0.55 92 –9.28 +3.6 ± 0.2 +13.0
Q127H 1.0 ± 0.4 1.26 ± 0.16 79 –9.36 +6.8 ± 0.1 +16.2
The values of stoichiometry n, binding constant KB, dissociation constant KD, free energy ∆G°, heat of interaction ∆H and entropy T∆S° measured
by ITC for different PH domains at 15°C.
Figure 8
A model for the activation of Btk on the membrane. In the resting
cells, Btk is cytosolic and inactive (a). Upon stimulation of the β-cell
receptor, PI3K is activated and generates PtdIns(3,4,5)P3. The Btk
PH domain anchors the enzyme on the plasma membrane, where Btk
is phosphorylated on Y551 in the activation loop of the kinase
domain by Src (b). Btk dimerizes via lateral interactions between two
PH domains (c). Dimeric Btk can trans-phosphorylate Y223 in the
SH3 domain, resulting in a fully active enzyme. Btk is released from
the membrane following dephosphorylation of PtdIns(3,4,5)P3 (d).
The red crosses indicate steps where different PH mutations affect
the normal activation pathway.
rapidly produced upon stimulation by the PI3K activity
[52]. Consequently, PH domains that bind to these lipids
have to interact with a much higher affinity and specificity
in comparison with other domains because of the transient
nature of the signal [36,37,42]. The structural studies
described above reveal the details of this interaction in the
case of the Btk PH domain. In particular, they show how
the backbone of the β1–β2 loop that contacts the 5-phos-
phate of Ins(1,3,4,5)P4 closes the binding site at one side,
which probably accounts for the high affinity and specific
binding. This binding mode might be common to the other
PH domains known to bind specifically to PtdIns(3,4,5)P3,
such as the domains of GRP-1 and cytohesin (Figure 1b).
All three variant PH domains of Btk crystallized in an
identical manner, as dimers with two molecules in the
asymmetric unit, despite different space groups (Table 1
and [29]). Dimerization involves the same interface
formed by the β1–β2 strands of the two monomers, where
the sidechains of residues 41–45 in the β strand interact in
an antiparallel mode. Using analytical ultracentrifugation
and gel filtration we have not been able to detect dimers
of the Btk domain in solution in the presence or absence
of Ins(1,3,4,5)P4. However, the dimer interface occupies a
surface (~1100 A2 per monomer) that is larger than the one
normally found in nonspecific crystal contacts [53–55].
The decrease of solvent-accessible area caused by dimer-
ization, as well as the number of hydrogen bonds stabi-
lizing the dimer (nine), are comparable with the values
observed for homodimers [56].
The dimerization tendency of the PH domains may have
biological relevance for signalling. For its full activation, Btk
undergoes autophosphorylation of the Y223 residue in the
SH3 domain [13,14], but it is not yet clear whether this
occurs via a cis or trans mechanism. The dimerization of PH
domains could take place on the membrane surface. This
can lead to the following model for the activation mecha-
nism of Btk. First, PI3K is activated by B-cell receptor
stimulation and generates the membrane-bound ligand,
PtdIns(3,4,5)P3. Second, Btk is recruited to the membrane
via anchorage of its PH domain to PtdIns(3,4,5)P3 and elec-
trostatic interactions where it dimerizes as a result of the
interaction of two PH domains. Third, the Y551 residue of
Btk is phosphorylated by the Src kinase, and the Y223
residue is phosphorylated in trans by the Btk dimer. This
completes the activation and generates stimuli for B-cell
maturation. Finally, a phosphatase such as SHIP dephos-
phorylates PtdIns(3,4,5)P3, leading to the release of Btk
from the membrane and to its inactivation (Figure 8). In
this model, the membrane would be an essential compo-
nent for dimerization, limiting the Btk mobility to two
dimensions, stabilizing this oligomeric state and regulating
activation of the kinase. Dimerization of the Btk PH
domain should be studied on lipid vesicles or lipid mono-
layers in order to test this model. 
Biological implications
Studies in this paper focus on the molecular basis of
defects in the membrane association of Bruton’s tyrosine
kinase (Btk), which cause a human immunodeficiency
called X-linked agammaglobulinemia. Btk is a key factor
for the maturation of B cells. A variety of point muta-
tions that result in a severe disease reside in the N-ter-
minal PH (pleckstrin-homology) domain. This domain
specifically binds phosphatidylinositol 3,4,5-trisphosphate,
causing Btk to respond to signalling via phosphatidylinosi-
tol 3-kinase. The crystal structures of the wild-type PH
domain and a mutant domain (E41K) in complex with
D-myo-inositol 1,3,4,5-tetrakisphosphate show that the
mutant phenotype has different causes. Some mutations
simply perturb the stability of the PH domain or the adja-
cent Btk motif. Other mutant proteins are able to fold, but
they display weakened binding of the phosphatidylinositol
3,4,5-trisphosphate head group in a specific binding site.
Two mutations have an effect on the electrostatic poten-
tial in the region surrounding the phosphatidylinositol-
binding site. The reversal of an electric charge in this
region can cause a loss of function (K19E) or a gain of
function (E41K). Finally, the Q127H mutation is pre-
dicted to perturb a different function, such as the inter-
action with a subunit of a trimeric G protein.
Materials and methods
Crystallization and data collection
Expression and purification of the PH domain from the wild-type Btk,
and the mutants E41K, R28C, K19E, Q127H and T117P was carried
out in E. coli strain BL21(DE3) as described previously [29]. A protein
concentration of 10 mg/ml was used for crystallization. Proteins crys-
tallized at room temperature in hanging drops. Mixing of the wild-type
and E41K domain with the ligand D-Ins(1,3,4,5)P4 was carried out
immediately before setting the crystallization drops in a molar ratio of
1:4. The crystals of the E41K mutant grew with 10% (w/v) PEG 4000
(Sigma, USA), 100 mM Na acetate pH 5.5, whereas the wild type
crystallized in 9% (w/v) PEG 4000, 100 mM Na acetate pH 4.9, 10%
(v/v) methanol. In both cases, cubic crystals appeared after 12 hours.
Each complex crystallized in the tetragonal space group I4122 with
cell dimensions a = b = 110.20 Å, c = 215.53 Å for the wild type, and
a = b = 110.78 Å, c = 215.60 Å for the E41 mutant. Calculation of
Matthews volume [57] gives Vm = 4.12 Å3/Da, assuming two mol-
ecules per asymmetric unit, which corresponds to 70.1% solvent
content. 2-methyl-2,4-pentanediol was added to a final concentration
of 20% (v/v) in the crystallization solution as a cryoprotectant during
data collection. Diffraction data were collected at 100K using a Mar
CCD detector on the ID14a beamline at ESRF synchrotron facility in
Grenoble. The images were processed using the programs XDIS-
PLAY, DENZO and SCALEPACK of the HKL package [58].
Structure determination and refinement 
The structure of the E41K mutant was solved by molecular replace-
ment using the program AMoRe [59] and the single polypeptide chain
of the refined R28C mutant structure [29] (PDB code 1btk) as a
search model. The rotation search was carried out in the resolution
range of 10.0–3.5 Å, with an outer radius of Patterson integration of
16.0 Å. The correct rotation solutions corresponded to peaks No. 1
(4.3σ) and No. 4 (3.4σ), as revealed by the translation function calcu-
lated with data in the 10.0–4.0 Å range. After rigid-body refinement, the
R factor was 0.426, and the correlation coefficient was 0.549 for dif-
fraction data between 20.0 and 3.5 Å. The initial model containing only
the two polypeptide chains was refined with TNT [60], and the R factor
dropped to 0.320 (15.0–2.1 Å). The Fo–Fc map contoured at 3.0σ
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clearly indicated positions of Ins(1,3,4,5)P4 and the zinc ions, and the
changed conformation of the β1–β2 loop in both molecules of the
asymmetric unit. Ligands as well as zinc ions were included in the
model and the β1–β2 loop was rebuilt. Several cycles of refinement of
atomic positions and B factors with gradual release of noncrystallo-
graphic-symmetry (NCS) constraints were carried out, alternating with
model-building sessions with the program O [61]. All diffraction data
(35.0–2.1 Å) were used throughout refinement, apart from a randomly
selected test set (6%) required for R-free calculations. Solvent posi-
tions were automatically assigned by peak-searching routines of TNT in
combination with the WATPEAK program from the CCP4 suite [62],
and they were also checked with the graphics program O for density
and hydrogen-bonding patterns. Inspection of the difference 2Fo–Fc
and Fo–Fc maps (at R factor 0.221, R free 0.312) of the mutant domain
showed the position of the second Ins(1,3,4,5)P4 molecule in the prox-
imity of residue K41 in each molecule within the asymmetric unit. The
ligand, which is located on the crystallographic twofold axis with
C2–C5 direction parallel to the symmetry element, was placed in the
electron density and included in the model with occupancies set to 0.5,
and refined thereafter as a rigid body. The refinement of positional and
temperature parameters converged to an R factor of 0.214 and R free
of 0.296 for diffraction data in the 35.0–2.1 Å resolution range.
Residues 84–86 of molecule A, and 80–87 of molecule B were not
clearly visible in electron-density maps and were not included in the
model. In order to cross-check the orientation, the ligands were deleted
from the model together with solvent molecules, and a random shift of
0.3 Å was applied to all atoms. The initial R factor of this model was
0.351 and it converged to 0.288 after 10 cycles of positional and tem-
perature-factor refinement. The 2Fo–Fc and Fo–Fc electron-density
maps calculated with this model clearly correspond to the position and
orientation of the ligand in the refined structure. 
The wild-type Btk PH–Ins(1,3,4,5)P4 complex crystallizes in the same
crystal form as the E41K mutant, and the refined coordinates of the
latter without the ligands, zinc ions and solvent molecules were used as
the starting model. This was submitted to the rigid-body refinement,
which reduced the R factor from 0.339 to 0.330 for the data between
35.0 and 4.0 Å. Subsequent positional and B-factor refinement with
NCS restraints against data in the 35.0–2.4 Å resolution range
reduced the R factor to 0.297. The location of Ins(1,3,4,5)P4 in each
subunit was clearly identified at this stage in the 2Fo–Fc and Fo–Fc
density maps. The ligand was built in the density, and the model was
refined by several cycles of TNT with NCS restraints, combined with
visual inspection of the model and water positions as located in the
Fo–Fc density maps. The refinement converged to an R factor of 0.234
and R free of 0.351 for diffraction data in the 35.0–2.4 Å resolution
range. Residues 83–88 of molecule A and 80–86 of molecule B were
not clearly visible in the electron density and were not included in the
model. Details on data collection, refinement statistics and final model
quality are given in Table 1. 
Isothermal titration calorimetry
All titration experiments were conducted using an MCS ITC system
(Microcal Inc., MA) as described elsewhere [51,63]. Protein solutions
were dialyzed against the buffer (10 mM TrisHCl pH 8.0, 100 mM
NaCl, 2 mM DTT). The same buffer was used to dilute a concentrated
stock solution of Ins(1,3,4,5)P4. Titrations were performed at 15°C, in a
series of 17 experiments, injecting, for each step, 15 µl of ligand
(100 µM) into protein samples (10 µM) in the ITC cell (1.4 ml). Heats of
dilution of ligand into buffer were determined with separate titrations
and subtracted from the raw data of the binding experiments prior to
analysis. Resulting data were fitted with least-squares regression using
ORIGIN Software (Microcal) and a model for a single class of binding
site, as indicated by the shape of the titrations [51]. Three parameters
were allowed to float in the fitting procedure: change in enthalpy of
interaction (∆H), binding constant (KB = 1/KD) and stoichiometry.
Values for the change in free energy (∆G°) and entropy (∆S°) for the
interactions were calculated by
–RT ln KB = ∆H–T∆S° = ∆G°
where T is the absolute temperature and R is the gas constant. The
data were close to the limits of detection of ITC and are therefore
affected by large apparent errors in measurement.
Other methods
D-Ins(1,3,4,5)P4 was synthesized from myo-inositol as described previ-
ously [64] and was used as the 8 K+ salt. 31P and 1H NMR spectra,
mass spectra and optical rotation were all in accord with the final struc-
ture. The electrostatic potential for the Btk PH domains were calculated
with the UHBD program [65], applying the finite difference Poisson–
Boltzmann equation.
Accession numbers
The structures of the wild-type and E41K complexes have been
deposited in the Protein Data Bank [66] with accession codes 1b55
and 1bwn, respectively.
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